cytarabine has been researched along with Leukemia P388 in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (46.81) | 18.7374 |
| 1990's | 21 (44.68) | 18.2507 |
| 2000's | 4 (8.51) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birnbaum, GI; Cheng, YC; Clarke-Katzenburg, RH; Gabe, EJ; Giziewicz, J; Lin, TS; Liu, MC; Luo, MZ; Mancini, WR; Prusoff, WH | 1 |
| Barchi, JJ; Driscoll, JS; Kelley, JA; Liu, PS; Marquez, VE; Plowman, J | 1 |
| Birnbaum, GI; Brankovan, V; Cheng, YC; Ghazzouli, I; Giziewicz, J; Lin, TS; Liu, MC; Prusoff, WH; Shen, ZY; Yang, JH | 1 |
| Bordoni, T; Cristalli, G; Franchetti, P; Geroni, C; Grifantini, M; Vittori, S | 1 |
| An, SH; Berdel, WE; Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; West, CR | 1 |
| Boots, MR; Duke, SS | 1 |
| Asou, K; Hirata, R; Ishikawa, M; Kanno, S; Shouji, A | 1 |
| Krepelka, J; Melka, M; Miko, M | 1 |
| Mego, M; Novotny, L; Rauko, P; Saiko, P; Schott, H; Szekeres, T | 1 |
| Allaudeen, HS; Chang, PK; Chu, MY; Itoh, YH; Sartorelli, AC | 1 |
| Kuliczkowski, K; Preisler, HD; Raza, A; Weidong, G | 1 |
| Hori, K; Naganuma, K; Sakurai, Y; Tsukagoshi, S; Tsuruo, T | 1 |
| Ambaye, RY; Gokhale, SV; Parchure, M | 1 |
| Burchenal, JH; Chou, TC; Fox, JJ; Lokys, L; Smith, RS; Su, TL; Watanabe, KA | 1 |
| Calabresi, P; Chu, MY; Srivastava, SP; Steim, JM; Tibbetts, LM; Turcotte, JG | 1 |
| Cheng, YC; Chu, CK; Gao, Z; Grove, KL; Guo, X; Liu, SH | 1 |
| Azuma, A; Hanaoka, K; Kamo, N; Kobayashi, T; Kurihara, A; Matsuda, A; Miyauchi, S; Sasaki, T; Tanaka, M | 1 |
| Hirano, S; Iguchi, H; Izumi, H; Matsushita, Y; Takeuchi, T; Tone, H | 1 |
| Ichikawa, H; Machida, Y; Nagai, T; Onishi, H; Takahata, T | 1 |
| Kiyota, T; Kuriyama, H; Watanabe, A | 1 |
| Berdel, WE; Bergmann, J; Brachwitz, H; Fichtner, I; Langen, P; Thomas, Y; Vollgraf, C | 1 |
| Endo, M; Machida, H; Matsuda, A; Miura, S; Sasaki, T; Tanaka, M; Yoshimura, Y | 1 |
| Hanaoka, K; Hisaoka, M; Ikeda, T; Iwabuchi, H; Kaneko, M; Kobayashi, T; Kurakata, S; Matsuda, A; Mitsuhashi, Y; Miura, S; Nakagawa, A; Nomura, T; Sasaki, T; Shibayama, T; Suzuki, M; Tanaka, K; Tanzawa, F; Tomida, A; Tsuruo, T; Wataya, Y | 1 |
| Choe, YH; Conover, CD; Greenwald, RB; Royzen, M; Wu, D | 1 |
| Borowski, V; Choe, YH; Conover, CD; Gervacio, Y; Greenwald, RB; Mehlig, M; Royzen, M; Wu, D | 1 |
| Kessel, D | 1 |
| Higashigawa, M; Kuwabara, H; Ohkubo, T; Ooi, K; Sakurai, M | 1 |
| Matsuda, A; Sasaki, T; Tanaka, M; Terao, T | 1 |
| Cao, S; Wu, S; Xue, Y; Zhen, Y | 1 |
| Czyzewska-Szafran, H; Danysz, A; Jastrzebski, Z; Jedrych, A; Sołtysiak-Pawluczuk, D | 1 |
| Azuma, A; Matsuda, A; Nakajima, Y; Sasaki, T; Tanaka, M | 1 |
| Higashigawa, M; Hori, H; Ido, M; Kawasaki, H; Kuwabara, H; Nagao, Y; Ohkubo, T; Sakurai, M | 1 |
| Balázová, E; Kéry, V; Novotný, L; Sandula, J; Ujházy, V | 1 |
| Arita, M; Fujii, A; Matsuda, A; Okumoto, T; Sakata, S; Sasaki, T; Ueda, T; Yamagami, K | 1 |
| Hamazaki, M; Higashigawa, M; Hori, H; Ido, M; Kawasaki, H; Kuwabara, H; Ohkubo, T; Sakurai, M; Taniguchi, K | 1 |
| Higashigawa, M; Hori, H; Kawasaki, H; Ohkubo, T; Sakurai, M; Yoshizumi, T | 1 |
| Iwabuchi, M; Takahashi, K | 1 |
| Chitnis, MP; Deshpande, SS; Satyamoorthy, K | 1 |
| Higashigawa, M; Hori, H; Kamiya, H; Kawasaki, H; Nobori, T; Ochiai, H; Ohkubo, T; Sakurai, M | 1 |
| Hamazaki, M; Higashigawa, M; Ido, M; Kamiya, H; Kawasaki, H; Ohkubo, T; Sakurai, M; Taniguchi, K | 1 |
| Dulmadge, DA; Griswold, DP; Laster, WR; Wilkoff, LJ | 1 |
| Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; West, CR | 1 |
| Harrison, SD; O'Dwyer, PJ; Trader, MW | 1 |
| Capizzi, RL; Rathmell, JP; White, JC | 1 |
| Kuliczkowski, K; Preisler, HD; Raza, A; Raza, AS; Zhao, SC | 1 |
| Hoshino, A; Ito, Y; Machida, S | 1 |
| Bankert, R; Mayers, G; Preisler, HD; Raza, A; Spiridonidis, C; Ucar, K | 1 |
47 other study(ies) available for cytarabine and Leukemia P388
| Article | Year |
|---|---|
Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Chemical Phenomena; Chemistry; Crystallization; Cytarabine; Deoxycytidine; Female; Humans; Leukemia L1210; Leukemia P388; Leukemia, Lymphoid; Mice; Molecular Structure; Nucleosides; Sarcoma 180; Simplexvirus; Tumor Cells, Cultured; X-Ray Diffraction | 1991 |
Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Arabinonucleosides; Cytidine; Drug Screening Assays, Antitumor; Injections, Intraperitoneal; Injections, Subcutaneous; Leukemia L1210; Leukemia P388; Mice; Pyrimidine Nucleosides; Pyrimidinones; Structure-Activity Relationship | 1991 |
Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
Topics: Animals; Antineoplastic Agents; Cell Line; Chemical Phenomena; Chemistry; Cytarabine; Leukemia L1210; Leukemia P388; Mice; Pyrimidine Nucleosides; Sarcoma 180; Structure-Activity Relationship; X-Ray Diffraction | 1991 |
Improved synthesis and antitumor activity of 1-deazaadenosine.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line; Female; HeLa Cells; Humans; Leukemia L1210; Leukemia P388; Mice; Ribonucleosides; Tubercidin; Uterine Cervical Neoplasms | 1987 |
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cytarabine; Drug Administration Schedule; Humans; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Solubility | 1986 |
Synthesis and biological evaluation of sparsomycin analogues.
Topics: Animals; Antibiotics, Antineoplastic; Biological Assay; Bone Marrow; DNA Replication; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia P388; Male; Mast-Cell Sarcoma; Mice; Mice, Inbred DBA; Protein Biosynthesis; Sparsomycin; Structure-Activity Relationship | 1983 |
Effects of naringin on cytosine arabinoside (Ara-C)-induced cytotoxicity and apoptosis in P388 cells.
Topics: Animals; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Catalase; Cell Nucleus; Comet Assay; Cytarabine; DNA Fragmentation; Flavanones; Glutathione Peroxidase; Leukemia P388; Mice; Microscopy, Fluorescence; Reactive Oxygen Species; Superoxide Dismutase; Tetrazolium Salts; Thiazoles | 2004 |
Primary screening of cytotoxic activity of 6-purinyl-N-(2-chlordethyl) thiocarbamate.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Cytarabine; Leukemia P388; Mercaptopurine; Mice; Mustard Compounds | 1989 |
In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytarabine; Dimerization; Female; Floxuridine; Inhibitory Concentration 50; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred DBA; Time Factors | 2007 |
Evaluation of 2,2'-anhydro-1-(3'-Ok-acetyl-beta-D-arabinofuranosyl)-5-iodocytosine hydrochloride and related compounds as antineoplastic and antiviral agents.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cells, Cultured; Cytarabine; Female; Leukemia L1210; Leukemia L5178; Leukemia P388; Macromolecular Substances; Mice; Nucleic Acid Synthesis Inhibitors; Simplexvirus | 1981 |
Comparison of in vitro assays for detecting subpopulations of P388 leukemic cells resistant to AraC.
Topics: Animals; Cell Survival; Cytarabine; DNA, Neoplasm; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Tritium | 1984 |
Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
Topics: Adenocarcinoma; Administration, Oral; Animals; Colonic Neoplasms; Cytarabine; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasms, Experimental | 1984 |
Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation, Preclinical; Drug Synergism; Fluorouracil; Folic Acid; Leukemia P388; Leukemia, Experimental; Methotrexate; Mice; Mitomycins | 1984 |
Activity of 2-fluoro-5-methylarabinofuranosyluracil against mouse leukemias sensitive to and resistant to 1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Arabinofuranosyluracil; Cells, Cultured; Cytarabine; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Pyrimidine Nucleosides | 1982 |
Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
Topics: Animals; Antineoplastic Agents; Cell Line; Cytarabine; Cytidine Diphosphate Diglycerides; Humans; Leukemia L5178; Leukemia P388; Mice; Neoplasms, Experimental; Nucleoside Diphosphate Sugars | 1980 |
Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Colonic Neoplasms; Cytarabine; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Humans; KB Cells; Leukemia P388; Liver Neoplasms; Male; Mice; Molecular Structure; Phosphorylation; Prostatic Neoplasms; Stereoisomerism; Tumor Cells, Cultured | 1995 |
Nucleosides and nucleotides. 141. Chemical stability of a new antitumor nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in alkaline medium: formation of 2'-C-cyano-2'-deoxy-1-beta-D-ribo-pentofuranosylcytosine and its antitumor act
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Cytarabine; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Leukemia P388; Mice; Mice, Inbred DBA; Ribonucleosides; Spectrum Analysis; Tumor Cells, Cultured | 1995 |
Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Leukemia P388; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Mitomycin; Peplomycin; Vindesine | 1994 |
Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Agents; Body Weight; Chitin; Chitosan; Cytarabine; Drug Carriers; Hydrogen-Ion Concentration; Leukemia P388; Longevity; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred Strains; Prodrugs; Spectrophotometry, Ultraviolet | 1993 |
[Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Screening Assays, Antitumor; Female; Idarubicin; Leukemia P388; Mice; Neoplasm Transplantation; Tumor Cells, Cultured | 1996 |
1-beta-D-Arabinofuranosylcytosine-5'-alkylphosphonophosphates and diphosphates: new orally active derivatives of ara-C.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Calcium; Cell Division; Cell Line; Cytarabine; Female; Humans; Leukemia P388; Mice; Molecular Structure; Phospholipid Ethers; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine.
Topics: Administration, Oral; Amination; Animals; Antineoplastic Agents; Cell Division; Cytarabine; Cytidine Deaminase; Female; Humans; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1998 |
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biotransformation; Breast Neoplasms; Cisplatin; Cytarabine; Cytosine; Deoxycytidine; Deoxycytidine Kinase; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; KB Cells; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Mitomycin; Molecular Structure; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Nude; Specific Pathogen-Free Organisms; Stomach Neoplasms; Tumor Cells, Cultured; Vincristine | 1999 |
Anticancer drug delivery systems: N4-acyl poly(ethyleneglycol) prodrugs of ara-C. I. Efficacy in solid tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Cytarabine; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Humans; Leukemia P388; Mice; Mice, Nude; Neoplasms; Polyethylene Glycols; Prodrugs; Solvents; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Anticancer drug delivery systems: multi-loaded N4-acyl poly(ethylene glycol) prodrugs of ara-C. II. Efficacy in ascites and solid tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Ehrlich Tumor; Cytarabine; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Mice; Mice, Nude; Polyethylene Glycols; Prodrugs; Solvents; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Enhanced glycosylation induced by adriamycin.
Topics: Animals; Biological Transport; Cell Membrane; Cytarabine; Doxorubicin; Electrophoresis; Glycoproteins; In Vitro Techniques; Leukemia P388; Male; Mice; Neoplasm Proteins; Solubility | 1979 |
[The effect of etoposide on influx and efflux of cytosine arabinoside in P388 murine leukemic cells].
Topics: Animals; Cytarabine; Depression, Chemical; Dose-Response Relationship, Drug; Etoposide; Leukemia P388; Mice; Tumor Cells, Cultured | 1992 |
Antitumor activity of a novel nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine (CNDAC) against murine and human tumors.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chick Embryo; Cytarabine; Cytidine Deaminase; Humans; Leukemia P388; Mice; Mice, Nude; Tumor Cells, Cultured | 1992 |
Green tea extract inhibits nucleoside transport and potentiates the antitumor effect of antimetabolites.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cytarabine; Drug Synergism; Female; Humans; Leukemia L1210; Leukemia P388; Male; Methotrexate; Mice; Mice, Inbred DBA; Plant Extracts; Tea; Thymidine; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uridine | 1991 |
Effect of solcoseryl on antitumour action and acute toxicity of some antineoplastic drugs.
Topics: Actihaemyl; Animals; Antineoplastic Agents; Cytarabine; Drug Interactions; Fluorouracil; Injections, Intraperitoneal; Injections, Intravenous; Lethal Dose 50; Leukemia P388; Male; Methotrexate; Mice; Mice, Inbred DBA; Mitoxantrone | 1991 |
Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.
Topics: Animals; Antineoplastic Agents; Cytarabine; DNA; Drug Design; Drug Screening Assays, Antitumor; Leukemia P388; Mice; Tumor Cells, Cultured | 1991 |
Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Blotting, Western; Cytarabine; DNA-Directed DNA Polymerase; Doxorubicin; Drug Resistance; Etoposide; Intracellular Fluid; Leukemia P388; Mice; Nucleic Acid Synthesis Inhibitors; Thymine Nucleotides; Tumor Cells, Cultured; Vincristine | 1991 |
Treatment of leukemia L1210 and P388 by arabinosylcytosine-polysaccharide conjugates.
Topics: Animals; beta-Glucans; Cytarabine; DNA; Female; Glucans; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred DBA; Pectins | 1991 |
Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
Topics: Animals; Cytarabine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms; Tumor Cells, Cultured | 1991 |
Membrane transport of 1-beta-D-arabinofuranosylcytosine and accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Binding Sites; Biological Transport; Cell Membrane; Cytarabine; Drug Resistance; Leukemia P388; Mice; Mice, Inbred Strains; Thioinosine; Tumor Cells, Cultured; Vincristine | 1991 |
Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Chromatography, High Pressure Liquid; Cytarabine; Cytidine Monophosphate; Deoxyribonucleotides; Leukemia P388; Male; Mice | 1990 |
[Kinetics of etoposide cytotoxicity against mouse P388 leukemia].
Topics: Animals; Bleomycin; Cell Cycle; Cell Survival; Cisplatin; Colony-Forming Units Assay; Cytarabine; Doxorubicin; Etoposide; Fluorouracil; Leukemia P388; Leukemia, Experimental; Melphalan; Mice; Peplomycin; Podophyllotoxin; Tumor Stem Cell Assay; Vinblastine | 1985 |
Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
Topics: Animals; Antimetabolites, Antineoplastic; Aphidicolin; Cytarabine; Diterpenes; DNA Polymerase II; DNA, Neoplasm; Doxorubicin; Drug Resistance; Hydroxyurea; Inosine; Leukemia P388; Leukemia, Experimental; Mice; Ribonucleotide Reductases; RNA, Neoplasm; Tumor Cells, Cultured | 1989 |
Intracellular pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cytarabine; DNA; Leukemia P388; Leukemia, Experimental; Mice; Tumor Cells, Cultured | 1989 |
Increased sensitivity to 1-beta-D-arabinofuranosylcytosine in P388 murine leukemic cells resistant to etoposide.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cell Line; Cytarabine; Deoxyribonucleotides; Drug Resistance; Etoposide; Leukemia P388; Leukemia, Experimental; Mice | 1989 |
Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
Topics: Alkaloids; Animals; Cell Survival; Cytarabine; Doxorubicin; Drug Resistance; Female; Gene Amplification; Harringtonines; Homoharringtonine; Leukemia P388; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Tumor Cells, Cultured; Vincristine | 1989 |
1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
Topics: Animals; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Structure-Activity Relationship | 1986 |
Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Leukemia P388; Leukemia, Experimental; Mice; Phosphonoacetic Acid; Ribavirin; Ribonucleosides; Thioguanine | 1986 |
Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells.
Topics: Acute Disease; Adult; Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Cell Line; Cell Membrane; Cytarabine; Humans; Kinetics; Leukemia; Leukemia L5178; Leukemia P388; Mathematics; Mice | 1987 |
Comparison of autoradiography and DNA histograms in assessing S-phase cells from patients with myeloid leukemias.
Topics: Animals; Autoradiography; Bone Marrow; Cells, Cultured; Cytarabine; DNA Replication; DNA, Neoplasm; Doxorubicin; Flow Cytometry; Humans; Interphase; Leukemia; Leukemia P388; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphocytes; Mice | 1985 |
[Effects of combination chemotherapy of MCNU with various anti-cancer agents].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Female; Fluorouracil; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mercaptopurine; Methotrexate; Mice; Mice, Inbred DBA; Mitomycin; Mitomycins; Nitrosourea Compounds; Thioguanine | 1985 |
Double labeling of S-phase murine cells with bromodeoxyuridine and a second DNA-specific probe.
Topics: Animals; Antibodies, Monoclonal; Autoradiography; Bromodeoxyuridine; Cell Cycle; Cytarabine; DNA; Leukemia P388; Mice; Thymidine; Tritium | 1985 |